Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07620353 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Observational Study of OROSEDAL in Sore Throat and Minor Oral Lesions

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This prospective, multicenter, national, observational, non-interventional post-market clinical follow-up study will evaluate the performance and safety of OROSEDAL in children and adults with sore throat or minor oral lesions, including minor aphthous ulcers and histologically confirmed oral lichen planus. OROSEDAL is prescribed in routine practice before inclusion. Patients will be followed for 6 ± 1 days and will complete self-assessments of pain, swallowing discomfort, treatment use, and adverse events.
Trial Details
NCT Number NCT07620353
Lead Sponsor Laboratoires Elerte
Collaborators: Clin-Experts
Conditions
(from sponsor)		 Sore Throat, Aphthous Ulcer, Oral Lichen Planus, Minor Mouth Lesion, Oral Pain
Related terms Lichen Planus, Oral, Oral Ulcer, Pharyngitis, Stomatitis, Aphthous
Enrollment 124 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov